Volv - AI Powered Global Healthcare - Booth

AI powering global reach for rare diseases

Volv's methodology for difficult to diagnose and rare disease modelling

inTrigue is a completely new way to discover patients that typically cannot be found in any other way. We build models based on patients that have not been found, not those that have already been found. That means using machine learning with no labels. It is frankly revolutionary, and a large hope for undiagnosed populations.

inTrigue: Be ready for truly personalised medicine

We use high-sensitivity, proprietary technology that can detect digital biomarkers for any human disease. We chose to focus on difficult to diagnose conditions, where there is significant unmet need.

With inTrigue, it is now possible to transform disease management and treatment at the individual patient level. We reshape medical practice and facilitate significantly earlier patient diagnosis and more accurate targeting.

What inTrigue does very well

inTrigue develops robust models that can find undiagnosed and misdiagnosed patient cohorts for difficult to diagnose diseases with a very high degree of accuracy.

inTrigue relearns the model in every country, as individual country systems and data are so different. We take account of differences in

• clinical thinking
• language
• data structures
• population variance

We unlock the way to find patients accurately in any language and in almost any available data set.